BioCryst Pharmaceuticals BCRX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 97.8%+0.8pp | 97.8%+0.5pp | 97.4%-0.7pp | 97%-1.5pp | 96.9%-1.7pp | |
| Operating margin | -43.1%-49.7pp | 39%+39.5pp | 12.7%+22.6pp | 9.7%+25.5pp | 6.6%+31.9pp | |
| Net margin | -51.7%-41.1pp | 30.2%+49.9pp | -1.5%+28.5pp | -6.4%+31.8pp | -10.6%+48.1pp | |
| Efficiency | ||||||
| Asset turnover | 1.9×+0.8× | 1.7×+0.8× | 1.3×+0.5× | 1.2×+0.4× | 1.1×+0.3× | |
| Liquidity | ||||||
| Current ratio | 1.9×-1.0× | 2.1×-0.6× | 1.9×-0.9× | 2.2×-0.6× | 2.9×-0.8× | |
| Per Share | ||||||
| Book value per share | -$2.29-8.9% | -$0.55+76.3% | -$1.76+22.1% | -$1.92+16.8% | -$2.10+9.1% | |
| Valuation | ||||||
| Market capitalization | $2.39B+52.3% | $1.64B+5.5% | $1.59B+1.3% | $2.08B+62.9% | $1.57B+49.7% | |
| Price / sales | 2.7×-0.4× | 1.9×-1.6× | 2.7×-1.2× | 3.7×+0.4× | 3.1×+0.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioCryst Pharmaceuticals's profit margins?
- BioCryst Pharmaceuticals (BCRX) runs a 97.8% gross margin and a -43.1% operating margin, with a -51.7% net margin.
- Where do BioCryst Pharmaceuticals's ratios come from?
- Every ratio is computed from BioCryst Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
